β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Oncology

• Publication date

  2014-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijo.2014.2448PMID 24841897
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brainstem Glioma: A Review

  2013cited by this paper
• Glioblastoma and other malignant gliomas: a clinical review.

  2013cited by this paper
• Chemotherapy plus radiotherapy versus radiotherapy alone in patients with anaplastic glioma: a systematic review and meta-analysis

  2013cited by this paper
• Temozolomide for high grade glioma.

  2013cited by this paper
• Surgical resection of malignant gliomas—role in optimizing patient outcome

  2013cited by this paper
• Characteristics of glioma stem cells

  2013cited by this paper
• β-elemene decreases cell invasion by upregulating E-cadherin expression in MCF-7 human breast cancer cells.

  2013cited by this paper
• Therapeutic strategies targeting glioblastoma stem cells.

  2013cited by this paper
• A review of the symptomatic management of malignant gliomas in adults.

  2013cited by this paper
• Potential role of β-elemene on histone H1 in the H22 ascites hepatoma cell line.

  2012cited by this paper
• CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.

  2012cited by this paper
• β-Elemene inhibits Hsp90/Raf-1 molecular complex inducing apoptosis of glioblastoma cells

  2012cited by this paper
• Targeting glioblastoma stem cells: cell surface markers.

  2012cited by this paper
• Chinese a Nti鄄 Cancer a Ssociation

  2012cited by this paper
• Breast cancer resistance protein(BCRP/ABCG2):its role in multidrug resistance and regulation of its gene expression

  2012cited by this paper
• Rac1+ cells distributed in accordance with CD 133+ cells in glioblastomas and the elevated invasiveness of CD 133+ glioma cells with higher Rac1 activity.

  2012cited by this paper
• β-elemene inhibits proliferation of human glioblastoma cells through the activation of glia maturation factor β and induces sensitization to cisplatin.

  2011cited by this paper
• Reversal of Resistance to Adriamycin in Human Gastric Cancer by β-elemene

  2011cited by this paper
• [Correlation between the distribution of CD133-positive cells and the proliferation of microvessels in glioblastoma multiforme].

  2011cited by this paper
• Correlation between glioblastoma stem-like cells and tumor vascularization.

  2011cited by this paper
• Correlation between the distribution of CD 133-positive cells and the proliferation of microvessels in glioblastoma multiforme ]

  2011cited by this paper
• ß-Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6.

  2011cited by this paper
• Chemoresistance of glioblastoma cancer stem cells - much more complex than expected

  2011cited by this paper
• Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma

  2010cited by this paper
• ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.

  2010cited by this paper
• The ABCG2 resistance network of glioblastoma

  2009cited by this paper
• The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

  2008cited by this paper
• Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation.

  2008cited by this paper
• Molecular Cancer BioMed Central

  2008cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• [Effect of p38 MAPK on elemene-induced cell cycle arrest in C6 glioblastoma cells].

  2008cited by this paper
• Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma

  2007cited by this paper
• A rapid assay for drug sensitivity of glioblastoma stem cells.

  2007cited by this paper
• HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity.

  2007cited by this paper
• Chemotherapy resistance of glioblastoma stem cells

  2006cited by this paper
• Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

  2006cited by this paper
• Glioblastoma‐derived tumorospheres identify a population of tumor stem‐like cells with angiogenic potential and enhanced multidrug resistance phenotype

  2006cited by this paper
• [Inhibition of eIF families expression and angiogenesis for human laryngeal carcinoma by elemene administration].

  2005cited by this paper
• Antiproliferative effect of β-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase

  2005cited by this paper
• Tumour stem cells and drug resistance

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients

  2004cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Isolation of cancer stem cells from adult glioblastoma multiforme

  2004cited by this paper
• Identification of a cancer stem cell in human brain tumors.

  2003cited by this paper
• The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors.

  2002cited by this paper
• Investigation of Tca8113 Cell Lines Differentiation Induced by β-elemene.

  2002cited by this paper
• [Supercritical fluid extraction of beta-elemene under lower pressure].

  2001cited by this paper
• Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

  1999cited by this paper

• Mechanistic insights into the therapeutic potential of β-elemene on glioma and other central nervous system diseases

  2025cites this paper
• The significance of epithelial–mesenchymal transition (EMT) in the initiation, plasticity, and treatment of glioblastoma

  2025cites this paper
• Curcumae Rhizoma: An anti-cancer traditional Chinese medicine

  2025cites this paper
• A review of natural products and small‐molecule therapeutics acting on central nervous system malignancies: Approaches for drug development, targeting pathways, clinical trials, and challenges

  2024cites this paper
• Beta-elemene: A phytochemical with promise as a drug candidate for tumor therapy and adjuvant tumor therapy.

  2024cites this paper
• β-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy

  2024cites this paper
• Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.

  2023cites this paper
• The complementary and alternative roles of elemene injection in cancer: an umbrella review.

  2023cites this paper
• Elemene Antitumor Drugs Development Based on “Molecular Compatibility Theory” and Clinical Application: A Retrospective and Prospective Outlook

  2023cites this paper
• β-elemene suppresses tumor metabolism and stem cell-like properties of non-small cell lung cancer cells by regulating PI3K/AKT/mTOR signaling.

  2022cites this paper
• Global research trends and hotspots on glioma stem cells

  2022cites this paper
• Integrated regulation of chondrogenic differentiation in mesenchymal stem cells and differentiation of cancer cells

  2022cites this paper
• Recent Advances in Understanding the Mechanisms of Elemene in Reversing Drug Resistance in Tumor Cells: A Review

  2021influential citation
• β-Elemene Enhances the Sensitivity of Osteosarcoma Cells to Doxorubicin via Downregulation of Peroxiredoxin-1

  2021cites this paper
• Therapeutic Perspective of Temozolomide Resistance in Glioblastoma Treatment

  2021cites this paper
• OTT_A_303152 3599..3609

  2021cites this paper
• Terpenoids from Curcumae Rhizoma: Their anticancer effects and clinical uses on combination and versus drug therapies.

  2021cites this paper
• Sesquiterpenes and their derivatives-natural anticancer compounds: An update.

  2020cites this paper
• Multi-Targeting by β-Elemene and Its Anticancer Properties: A Good Choice for Oncotherapy and Radiochemotherapy Sensitization

  2020cites this paper
• Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems.

  2020cites this paper
• Solid lipid nanoparticles as a drug delivery system to across the blood-brain barrier.

  2019cites this paper
• Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review.

  2019cites this paper
• Antitumor effects of β-elemene via targeting the phosphorylation of insulin receptor

  2018cites this paper
• Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy

  2018cites this paper
• HIF1α regulates glioma chemosensitivity through the transformation between differentiation and dedifferentiation in various oxygen levels

  2017cites this paper
• Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy.

  2017cites this paper
• Selectivity of supercritical CO2 extraction and atmospheric pressure techniques for the major volatile compounds of Eugenia involucrata leaves from Southern Brazil

  2017cites this paper
• β-elemene inhibits tumor-promoting effect of M2 macrophages in lung cancer.

  2017cites this paper
• β-Elemene treatment of glioblastoma: a single-center retrospective study

  2016cites this paper
• Molecular Mechanisms of Anti-cancer Activities of β-elemene: Targeting Hallmarks of Cancer.

  2016cites this paper
• β‐Elemene Selectively Inhibits the Proliferation of Glioma Stem‐Like Cells Through the Downregulation of Notch1

  2016cites this paper
• Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules

  2015cites this paper
• The reversal of antineoplastic drug resistance in cancer cells by β-elemene

  2015cites this paper